Hemophilia C

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Hemophilia C trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT04278404

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca…

The study investigators are interested in learning more about how drugs, that are given to children by their health care provider, act in the bodies of children…

United States5,000 participantsStarted 2020-03-05

Treatment: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care:

All recent trials (18 shown)

By InvitationNot Applicable

NCT03655223

Early Check: Expanded Screening in Newborns

Early Check provides voluntary screening of newborns for a selected panel of conditions. The study has three main objectives: 1) develop and implement an approa…

United States30,000 participantsStarted 2018-10-15

Treatment: Confirmatory Testing

UnknownNot Applicable

NCT05565690

Role of MRS in Brain Lesions

Aim of the study is evaluation of accuracy of magnetic resonance spectroscopy in differentiation between neoplastic and non neoplastic lesions and determination…

Location not specified64 participantsStarted 2022-10-01

Treatment: MRS

Hemophilia C

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca…

All recent trials (18 shown)

Early Check: Expanded Screening in Newborns

Role of MRS in Brain Lesions

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Ca…

All recent trials (18 shown)

Early Check: Expanded Screening in Newborns

Role of MRS in Brain Lesions

Safety and Efficacy Study in Subjects With Chronic HCV and Underlying Hemophilia

Raloxifene on Coagulation System in the Postmenopausal Women

Host Genetic Factors Influencing HIV1 and HCV Viral Loads and AIDS Clinical Progression in a Hemophilia Cohort (HGDS-3)

The Second Multicenter Hemophilia Cohort Study

Bioequivalence of NovoSeven® and a NovoSeven® Formulation Stable at Room Temperature in Healthy Male Subjects

A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Plus Ribavirin in Hemophiliac Patients With Chronic Hepatitis C.

Hepatitis C in Clinically Discordant Hemophilic Siblings

Evaluation of Clot Stability Induced by Solulin: Evaluation of New Solulin Mutants Lacking Protein C Activation Capacity

The Proteins of the Contact Activation System

Viral Kinetics in HCV Clearance in Subjects With Hemophilia

Open-Labeled Study of PSI-7977 and RBV With and Without PEG-IFN in Treatment-Naïve Patients With HCV GT2 or GT3

HEMOLEVEN® Expanded Access Program Prevention of Surgical/Postpartum Hemorrhage Severe Inherited Factor XI Deficiency

A Single and Low Dose of Recombinant Factor VIIa in Patients With Severe Factor XI Deficiency Undergoing Surgery

Pegasys® Plus Ribavirin in Hemophilic Patients With Hepatitis C Virus Infection

Treatment of Hepatitis C in Hemophilic Patients With HIV